We studied the role of cytokines TGF-β and TNFα in reduction of the cytolytic activity of NK cells towards tumor cells. Exogenous TGF-β and TNFα reduced the sensitivity of MiaPaCa2 pancreatic adenocarcinoma cells to NK cytotoxicity, which was associated with reduction of ULBP-1 expression and increase of HLA-E, HLA-G, CD155, and CD112 expression on Mia-PaCa2 cells. Changes in the expression of ligands for NK receptors on tumor cells induced by TGF-β and TNFα may contribute to reduction of cytotoxicity of tumor-associated NK cells and thus prevent an adequate antitumor immune response leading to the disease progress.
Similar content being viewed by others
References
Allard M, Oger R, Vignard V, Percier JM, Fregni G, Périer A, Caignard A, Charreau B, Bernardeau K, Khammari A, Dréno B, Gervois N. Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer. PLoS One. 2011;6(6):e21118. doi: https://doi.org/10.1371/journal.pone.0021118.
Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25(3):409-416.
Blake SJ, Dougall WC, Miles JJ, Teng MW, Smyth MJ. Molecular pathways: targeting CD96 and TIGIT for cancer immunotherap. Clin. Cancer Res. 2016;22(21):5183-5188.
Carlsten M, Björkström NK, Norell H, Bryceson Y, van Hall T, Baumann BC, Hanson M, Schedvins K, Kiessling R, Ljunggren HG, Malmberg KJ. DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res. 2007;67(3):1317-1325.
Carlsten M, Norell H, Bryceson YT, Poschke I, Schedvins K, Ljunggren HG, Kiessling R, Malmberg KJ. Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells. J. Immunol. 2009; 183(8):4921-4930.
Cerwenka A, Lanier LL. Ligands for natural killer cell receptors: redundancy or specificity. Immunol. Rev. 2001;181:158-169.
Friess H, Yamanaka Y, Büchler M, Ebert M, Beger HG, Gold LI, Korc M. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology. 1993;105(6):1846-1856.
Guan Z, Song B, Liu F, Sun D, Wang K, Qu H. TGF-b induces HLA-G expression through inhibiting miR-152 in gastric cancer cells. J. Biomed. Sci. 2015;22:107. doi: https://doi.org/10.1186/s12929-015-0177-4.
Maier MK, Seth S, Czeloth N, Qiu Q, Ravens I, Kremmer E, Ebel M, Müller W, Pabst O, Förster R, Bernhardt G. The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens. Eur. J. Immunol. 2007;37(8):2214-2225.
Morandi F, Pistoia V. Interactions between HLA-G and HLA-E in physiological and pathological conditions. Front. Immunol. 2014;5:394. doi:https://doi.org/10.3389/fimmu.2014.00394.
Peng YP, Xi CH, Zhu Y, Yin LD, Wei JS, Zhang JJ, Liu XC, Guo S, Fu Y, Miao Y. Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer. Oncotarget. 2016;7(41):66 586-66 594.
Stanietsky N, Simic H, Arapovic J, Toporik A, Levy O, Novik A, Levine Z, Beiman M, Dassa L, Achdout H, Stern-Ginossar N, Tsukerman P, Jonjic S, Mandelboim O. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc. Natl Acad. Sci. USA. 2009;106(42):17,858-17,863.
Wu X, Ma J, Han JD, Wang N, Chen YG. Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors. Microvasc. Res. 2006;71(1):12-19.
Yang Y, Geraghty DE, Hunt JS. Cytokine regulation of HLA-G expression in human trophoblast cell lines. J. Reprod. Immunol. 1995;29(3):179-195.
Zhang Z, Su T, He L, Wang H, Ji G, Liu X, Zhang Y, Dong G. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma. Tohoku J. Exp. Med. 2012;226(1):59-68.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 165, No. 2, pp. 224-228, February, 2018
Rights and permissions
About this article
Cite this article
Ostapchuk, E.O., Kali, A. & Belyaev, N.N. Transforming Growth Factor-β and Tumor Necrosis Factor-α Reduce the Sensitivity of MiaPaCa2 Pancreatic Cancer Cells to Lysis by NK Cells. Bull Exp Biol Med 165, 259–263 (2018). https://doi.org/10.1007/s10517-018-4143-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-018-4143-5